Comparison of Medtronic CoreValve and Edwards SAPIEN XT for transcatheter aortic valve implantation: the need for an imaging-based personalized approach in device selection

Affiliations

¹ Department of Interventional Cardiology, Thorax Centre, Rotterdam, the Netherlands; Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom.
² Department of Interventional Cardiology, Thorax Centre, Rotterdam, the Netherlands; Department of Cardiology, Imperial College London, London, United Kingdom. Electronic address: p.w.j.c.serruys@erasmusmc.nl.

Free article

Editorial

Javaid Iqbal et al. JACC Cardiovasc Interv. 2014 Mar.

Free article

. 2014 Mar;7(3):293-5.

doi: 10.1016/j.jcin.2014.01.147.

¹ Department of Interventional Cardiology, Thorax Centre, Rotterdam, the Netherlands; Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom.
² Department of Interventional Cardiology, Thorax Centre, Rotterdam, the Netherlands; Department of Cardiology, Imperial College London, London, United Kingdom. Electronic address: p.w.j.c.serruys@erasmusmc.nl.

No abstract available

Keywords: CoreValve; TAVI; aortic regurgitation; aortic stenosis; device selection; transcatheter aortic valve implantation.

Comment on

Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience.
Abdel-Wahab M, Comberg T, Büttner HJ, El-Mawardy M, Chatani K, Gick M, Geist V, Richardt G, Neumann FJ; Segeberg-Krozingen TAVI Registry. Abdel-Wahab M, et al. JACC Cardiovasc Interv. 2014 Mar;7(3):284-92. doi: 10.1016/j.jcin.2013.11.011. JACC Cardiovasc Interv. 2014. PMID: 24650401 Clinical Trial.